Pharmacy
Ir al canal en Telegram
@ph0md كل ما يخص كلية الصيدلة/جامعة كركوك-الدفعة الرابعة 2026 (دفعة اسود الرافدين)
Mostrar más604
Suscriptores
Sin datos24 horas
-37 días
-730 días
Archivo de publicaciones
604
اسئلة المد سهلة و سطحية 60 امسكيو نمط جات و اسئلة الفاينل سهلة جدا نمط جات 100 امسكيو
د.سفين
604
اسئلة المد 60 امسكيو مركزة و متوسطة نفس نمط الكوزات اعلاه ⬆️
و الفاينل 100 امسكيو متوسطة و يحتاج قاري مادة بتركيز.
dr.Gulden
604
1) Which of the following is NOT a primary objective of preclinical studies in drug development?
A. Determining pharmacologic activity
B. Assessing toxicologic effects
C. Establishing therapeutic application potential
D. Validating commercial advertising strategies
D2) Phase 1 clinical trials are primarily designed to: A. Evaluate long-term efficacy in large populations B. Assess safety, tolerability, and pharmacokinetics C. Compare the new drug with existing therapies D. Establish final dosage forms for marketing
B3) Filing an NDA with the FDA requires submission of evidence that: A. The drug is safe, effective, and manufactured under proper controls B. The drug has superior marketing potential compared to competitors C. The drug has completed Phase 4 studies D. The drug has been approved by international agencies
A4) During drug development, why is validation of manufacturing processes critical? A. To ensure compliance with quality standards B. To reduce advertising costs C. To accelerate Phase 1 trials D. To bypass FDA review
A5) After FDA approval, Phase 4 studies are conducted primarily to: A. Validate advertising strategies B. Monitor long-term safety C. Redefine preclinical toxicology D. Replace Phase 2 data
B6) The preclinical stage of drug development typically averages 6½ years. Which of the following best explains why this stage is so lengthy? A. Extensive marketing and promotional planning B. For both short-term and long-term animal testing C. FDA review of labeling and packaging D. Mandatory Phase 4 surveillance before clinical trials
B7) Based on the schematic representation of drug development, what is the approximate average time from initial synthesis to NDA approval? A. 7 years B. 10 years C. 15 years D. 20 years
C8) Which of the following best describes the rationale for placing certain drugs, such as those for AIDS or cancer, on an accelerated approval program? A. To bypass all preclinical studies B. To provide earlier access to promising therapies C. To reduce the cost of manufacturing validation D. To eliminate Phase 3 trials entirely
B9) Which of the following correctly matches the vaccine with its animal-derived culture system? A. Rubella vaccine – duck embryo B. Poliomyelitis vaccine – chick embryo fluid C. Influenza vaccine – bovine calf skin D. Smallpox vaccine – monkey renal tissue
A10) The advent of genetic engineering, involving manipulation of DNA, has enabled: A. The production of exclusively plant-derived antibiotics B. Vastly purer and more abundant biologic products, including vaccines and antibiotics C. The elimination of protein-based drugs from clinical practice D. The restriction of drug development to monoclonal antibody techniques.
B🟢اسئلة الكوز Drug Delivery (lec 1)
¡Ya disponible! Investigación de Telegram 2025 — los principales insights del año 
